The GvHD Hub
is a global online resource guided by an international steering committee of world experts in graft-versus-host disease (GvHD). The Hub disseminates clinical updates in GvHD and provides vital information for research and stem cell transplantation treatment teams. With an ever-expanding social media presence, the GvHD Hub engages with the global community on all major social media networks, providing the latest updates on everyday, real-world clinical practice.
The GvHD Hub is designed to deliver upon an unmet need for targeted medical updates, to help treatment teams involved in GvHD-care make informed therapeutic decisions. The GvHD Hub is run in collaboration with the European LeukemiaNet. The GvHD Hub is facilitated by Scientific Education Support (SES), who love nothing more than building communities and networks to enhance the level of collective knowledge, using multichannel communications to disseminate medical advances.
In the first quarter of 2020, the GvHD Hub presented a new editorial theme, novel therapies for the treatment of GvHD, and virtually covered the Transplantation & Cellular Therapy (TCT) Meeting, where it was recognized as one of the top influencers on Twitter. Since the beginning of 2020, the GvHD Hub published more than 20 articles about new clinical trial data, identification of new therapeutic targets, and guideline updates.
The GvHD Hub would like to thank the Silver supporter Incyte, Bronze supporter Novartis, and Contributor Bristol-Myers Squibb for their continued support of the initiative.
For more information on the GvHD Hub, please visit www.gvhdhub.com. For media enquiries or to explore collaboration opportunities, please contact: email@example.com.
Press release distributed by Pressat on behalf of Scientific Education Support, on Thursday 2 April, 2020. For more information subscribe and follow https://pressat.co.uk/